Free shipping on all orders over $ 500

Tucatinib

Cat. No. M10038

All AbMole products are for research use only, cannot be used for human consumption.

Tucatinib Structure
Synonym:

Irbinitinib; ARRY-380; ONT-380

Size Price Availability Quantity
10mM*1mL in DMSO USD 70  USD70 In stock
1mg USD 30  USD30 In stock
5mg USD 50  USD50 In stock
10mg USD 85  USD85 In stock
25mg USD 150  USD150 In stock
50mg USD 225  USD225 In stock
200mg USD 700  USD700 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tucatinib, also known as Irbinitinib and ONT-380, is an orally bioavailable inhibitor of the human epidermal growth factor receptor tyrosine kinase ErbB-2 (HER2). Irbinitinib selectively binds to and inhibits the phosphorylation of ErbB-2, which may prevent the activation of ErbB-2 signal transduction pathways, resulting in growth inhibition and death of ErbB-2-expressing tumor cells.

Chemical Information
Molecular Weight 480.52
Formula C26H24N8O2
CAS Number 937263-43-9
Solubility (25°C) DMSO 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Nancy U Lin, et al. J Clin Oncol. Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

[2] Anita Kulukian, et al. Mol Cancer Ther. Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models

[3] Rashmi K Murthy, et al. N Engl J Med. Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

[4] Cancer Discov. Tucatinib Impresses in Breast Cancer

Related EGFR/HER2 Products
Sevabertinib

Sevabertinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with antitumor activity.

BPIQ-I

BPIQ-I (PD 159121) is a potent and ATP-competitive EGFR tyrosine kinase inhibitor..

HKI-357 

HKI-357 is an irreversible dual inhibitor of EGFR and ERBB2 with IC50s of 34 nM and 33 nM, respectively.

SJF-1528 

SJF-1528 is a potent EGFR PROTAC degrader with DC50 values of 39.2 nM and 736.2 nM for wild-type EGFR in OVCAR8 cells and Exon 20 Ins mutated EGFR in HeLa cells.

CH7233163 

CH7233163 is a noncovalent ATP-competitive inhibitor for EGFR-Del19/T790M/C797S.

  Catalog
Abmole Inhibitor Catalog




Keywords: Tucatinib, Irbinitinib; ARRY-380; ONT-380 supplier, EGFR/HER2, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.